Novel affinity ligands for chromatography using combinatorial chemistry.

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Pharmacology

Background:

• Human serum albumin (HSA) is a crucial carrier protein in the bloodstream, influencing drug pharmacokinetics and pharmacodynamics.
• Developing small molecules with high affinity for specific HSA binding sites is essential for drug design and delivery.
• Combinatorial chemistry offers a powerful approach for rapidly synthesizing and screening diverse compound libraries.

Purpose of the Study:

• To synthesize and screen spatially addressable combinatorial libraries for binding to human serum albumin (HSA).
• To identify potent small molecule ligands with high binding affinity for HSA.
• To investigate the binding site and kinetics of identified ligands on HSA.

Main Methods:

• Solution phase chemistry was employed to synthesize spatially addressable combinatorial libraries.
• Screening assays were performed to identify compounds with binding affinity to HSA.
• Surface plasmon resonance (SPR) was used to characterize binding kinetics after ligand immobilization.

Main Results:

• Arylidene diamide library members exhibited submicromolar binding affinities to HSA, indicating potent interactions.
• Analysis of substituent frequency revealed key structural features contributing to high binding potency.
• Ibuprofen affected binding kinetics, while phenylbutazone did not, suggesting a specific binding site.

Conclusions:

• Arylidene diamides represent a promising class of compounds for targeting human serum albumin.
• The binding characteristics suggest these compounds likely interact with Site 2 in sub domain IIIA of HSA.
• This study provides valuable structure-activity relationship insights for designing HSA-binding ligands.